Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Birabresib (MK-8628) is a synthetic, small molecule inhibitor of the BET (Bromodomain and Extra-Terminal) family of bromodomain-containing proteins 2, 3 and 4 with potential antineoplastic activity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 41.00 | |
5 mg | In stock | $ 67.00 | |
10 mg | In stock | $ 87.00 | |
25 mg | In stock | $ 153.00 | |
50 mg | In stock | $ 247.00 | |
100 mg | In stock | $ 417.00 | |
200 mg | In stock | $ 622.00 | |
500 mg | In stock | $ 992.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 72.00 |
Description | Birabresib (MK-8628) is a synthetic, small molecule inhibitor of the BET (Bromodomain and Extra-Terminal) family of bromodomain-containing proteins 2, 3 and 4 with potential antineoplastic activity. |
Targets&IC50 | BRDs:10-19 nM(EC50) |
In vitro | OTX015 inhibits the binding of BRD2, BRD3, and BRD4 to AcH4 with IC50 ranging from 92 to 112 nM, and inhibits the growth of a variety of human cancer cell lines with GI50 ranging from 60 to 200 nM. [1] OTX015 results in rapid down-regulation of c-MYC expression, and show the synergistic anti-proliferative effects in combination with ALK inhibitors in ALKpos ALCL cell lines. [2] |
In vivo | OTX015 (p.o.) significantly inhibits the growth of Ty82 BRD-NUT midline carcinoma tumors in nude mice by 79% at 100 mg/kg qd and 61% at 10 mg/kg bid, respectively. [1] |
Kinase Assay | TR-FRET Assay <a href="#s_ref" class="sref">[1]: To assess binding of OTX015 to BRD2, BRD3, and BRD4, BRD-expressing CHO cell lysate (from CHO cells transfected with expression plasmids for Flag-tagged BRD2, BRD3, or BRD4 or vector alone), europium-conjugated anti-Flag antibody, XL-665-conjugated streptavidin, and biotinylated OTX015 are incubated at room temperature for 0.2 to 2 h. Fluorescence is measured by TR-FRET using an EnVision 2103 Multilabel Reader and EC50 for binding is calculated by nonlinear regression using PRISM version 5.02. |
Cell Research | Effects of OTX015 on cancer cell proliferation are evaluated by incubating human tumor cells for 72 h with increasing concentrations of OTX015 and assessing proliferation using a tetrazolium salt (WST-8)-based colorimetric assay.(Only for Reference) |
Synonyms | OTX-015, OTX015 (MK 8628/Birabresib), MK-8628 |
Molecular Weight | 491.99 |
Formula | C25H22ClN5O2S |
CAS No. | 202590-98-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 9.8 mg/mL (20 mM)
DMSO: 49.2 mg/mL (100 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Birabresib 202590-98-5 Chromatin/Epigenetic Epigenetic Reader Domain OTX 015 Inhibitor OTX-015 OTX015 MK8628 MK 8628 MK 8628/Birabresib OTX015 (MK 8628/Birabresib) inhibit MK-8628 inhibitor